Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Eli Lilly Corp. buy Wolfe Research

Eli Lilly Corp.
Start price
€895.10
21.05.26 / 50%
Target price
-
21.05.27
Performance (%)
17.22%
Price
€1,049.2
13.08.26
Summary
This prediction is currently active. The prediction currently has a performance of 17.22%. This prediction currently runs until 21.05.27. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Eli Lilly Corp. 1.392% 1.392%
iShares Core DAX® 0.881% 5.632%
iShares Nasdaq 100 2.390% 1.571%
iShares Nikkei 225® 4.269% 2.521%
iShares S&P 500 1.171% 2.545%

Comments by Wolfe_Research for this prediction

In the thread Eli Lilly Corp. diskutieren

Eli Lilly and Company (LLY) had its "outperform" rating reaffirmed by Wolfe Research.
Ratings data for LLY provided by MarketBeat

Wolfe Research 
0
Report Share
21.05.26 Buy 17.22%

Stopped prediction by Wolfe_Research for Eli Lilly Corp.

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€890.10
03.12.25
€1,074.1
03.12.26
17.87%
13.08.26

Wolfe Research 
03.12.25 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€732.30
15.11.24
€946.80
15.11.25
20.70%
16.11.25

Wolfe Research 
15.11.24 50%